Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
14.99
+0.69 (4.83%)
At close: Oct 22, 2026
| Market Cap | 173.63M +28.6% |
| Revenue (ttm) | 92.94M +385.7% |
| Net Income | 3.27M +1,933.5% |
| EPS | 0.24 +691.8% |
| Shares Out | 11.58M |
| PE Ratio | 61.34 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 816 |
| Open | 14.30 |
| Previous Close | 14.30 |
| Day's Range | 14.30 - 16.25 |
| 52-Week Range | 12.71 - 31.49 |
| Beta | -1.61 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |